Literature DB >> 31013249

A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Willy A Flegel1,2, Thierry Peyrard3, Jacques Chiaroni4,5, Christophe Tournamille6,7, Déborah Jamet8, France Pirenne6,7.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 31013249      PMCID： PMC6476736          DOI： 10.2450/2018.0059-18

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  22 in total

1.  Weak D alleles express distinct phenotypes.

Authors:  F F Wagner; A Frohmajer; B Ladewig; N I Eicher; C B Lonicer; T H Müller; M H Siegel; W A Flegel
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

2.  Outliers in RhD membrane integration are explained by variant RH haplotypes.

Authors:  Xinjian Yu; Franz F Wagner; Bernd Witter; Willy A Flegel
Journal:  Transfusion       Date:  2006-08       Impact factor: 3.157

3.  Weak D type 2 is the most prevalent weak D type in Portugal.

Authors:  F Araújo; M-J Rodrigues; F Monteiro; T Chabert; G Tavares; G Sousa; J Storry; J-E Guimarães
Journal:  Transfus Med       Date:  2006-02       Impact factor: 2.019

4.  A proposal to standardize terminology for weak D antigen.

Authors:  P C Agre; D M Davies; P D Issitt; B M Lamy; P J Schmidt; M Treacy; V Vengelen-Tyler
Journal:  Transfusion       Date:  1992-01       Impact factor: 3.157

5.  Weak D type 1, 2 and 3 subtype alleles are rare in the Western French population.

Authors:  L Raud; C Le Maréchal; C Férec; Y Fichou
Journal:  Transfus Med       Date:  2017-11-22       Impact factor: 2.019

6.  Strategies to identify candidates for D variant genotyping.

Authors:  Xunda Luo; Margaret A Keller; Ian James; Michelle Grant; Shiguang Liu; Kellie Simmons Massey; Andrew Czulewicz; Sandra Nance; Yanhua Li
Journal:  Blood Transfus       Date:  2017-04-05       Impact factor: 3.443

7.  Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.

Authors: 
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

8.  [System RH: screening of partials D with RHD/RHCE hybrid gene].

Authors:  M Ouchari; S Jemni Yacoub; B Houissa; S Abdelkefi; T Chakroun; M Bouslama; I Jerray; S Belhedi; S Hmida
Journal:  Transfus Clin Biol       Date:  2013-03-21       Impact factor: 1.406

9.  Anti-D auto-immunization in a patient with weak D type 4.0.

Authors:  M Ouchari; T Chakroun; S Abdelkefi; H Romdhane; B Houissa; S Jemni Yacoub
Journal:  Transfus Clin Biol       Date:  2013-12-22       Impact factor: 1.406

10.  Serologic and molecular characterization of weak D type 29.

Authors:  Mouna Ouchari; Kshitij Srivastava; Andrea Döscher; Roland Conradi; Saloua Jemni Yacoub; Franz Friedrich Wagner; Willy Albert Flegel
Journal:  Transfusion       Date:  2017-07-03       Impact factor: 3.157
View more
  4 in total

1.  Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele.

Authors:  Q Yin; K Srivastava; D G Brust; W A Flegel
Journal:  Immunohematology       Date:  2021-03

2.  What constitutes the most cautious approach for a pregnant person with weak D type 4.0?

Authors:  Willy Albert Flegel; Melanie Bodnar; Gwen Clarke; Judith Hannon; Lani Lieberman
Journal:  CMAJ       Date:  2021-06-14       Impact factor: 8.262

3.  Proceed with care: the "uncommon" serologic weak D phenotypes.

Authors:  Willy Albert Flegel
Journal:  Blood Transfus       Date:  2021-07       Impact factor: 3.443

4.  It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.

Authors:  Willy A Flegel; Gregory A Denomme; John T Queenan; Susan T Johnson; Margaret A Keller; Connie M Westhoff; Louis M Katz; Meghan Delaney; Ralph R Vassallo; Clayton D Simon; S Gerald Sandler
Journal:  Transfusion       Date:  2020-03-12       Impact factor: 3.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.